Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $130.88 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $60.16 | 2 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $30.21 | 1 | $0 (2024) |
| Foundation Medicine, Inc. | $15.54 | 1 | $0 (2022) |
| UROVANT SCIENCES INC | $13.01 | 1 | $0 (2022) |
| GENZYME CORPORATION | $11.96 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.21 | 1 | VERTEX PHARMACEUTICALS INCORPORATED ($30.21) |
| 2023 | $60.16 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($60.16) |
| 2022 | $40.51 | 3 | Foundation Medicine, Inc. ($15.54) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $30.21 | General |
| 08/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Oncology | ||||||
| 01/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Oncology | ||||||
| 11/07/2022 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Oncology | ||||||
| 07/01/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $13.01 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 632 | 659 | $88,765 | $25,330 |
| 2022 | 9 | 421 | 429 | $66,414 | $17,172 |
| 2021 | 7 | 324 | 336 | $41,479 | $12,422 |
| 2020 | 4 | 214 | 222 | $29,061 | $9,691 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 48 | 48 | $22,512 | $5,574 | 24.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 98 | 98 | $17,558 | $5,469 | 31.1% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 63 | 63 | $12,661 | $4,279 | 33.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 143 | 146 | $10,664 | $3,426 | 32.1% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 48 | 48 | $9,360 | $2,322 | 24.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 19 | 21 | $4,030 | $912.38 | 22.6% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 132 | 151 | $2,705 | $867.24 | 32.1% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 24 | 25 | $3,296 | $851.13 | 25.8% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 18 | 18 | $2,430 | $797.92 | 32.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 11 | 11 | $2,200 | $376.42 | 17.1% |
| 76870 | Ultrasound scan of scrotum | Office | 2023 | 13 | 14 | $905.00 | $320.88 | 35.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 16 | $444.00 | $134.38 | 30.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2022 | 83 | 85 | $17,345 | $4,717 | 27.2% |
| 77067 | Screening mammography | Office | 2022 | 29 | 29 | $13,601 | $3,418 | 25.1% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2022 | 36 | 36 | $8,172 | $2,342 | 28.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 25 | 26 | $8,350 | $2,020 | 24.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 72 | 74 | $6,868 | $1,616 | 23.5% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 30 | 30 | $5,850 | $1,468 | 25.1% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 20 | 20 | $3,492 | $864.51 | 24.8% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 111 | 114 | $2,280 | $617.22 | 27.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 15 | 15 | $456.00 | $108.96 | 23.9% |
| 74176 | Ct scan of abdomen and pelvis | Office | 2021 | 83 | 86 | $17,028 | $5,059 | 29.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2021 | 51 | 51 | $11,577 | $3,439 | 29.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2021 | 20 | 23 | $4,738 | $1,450 | 30.6% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2021 | 45 | 47 | $3,948 | $1,205 | 30.5% |
About Dr. John Gambino, MD
Dr. John Gambino, MD is a Diagnostic Radiology healthcare provider based in Ontario, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093773533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Gambino, MD has received a total of $130.88 in payments from pharmaceutical and medical device companies, with $30.21 received in 2024. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($130.88).
As a Medicare-enrolled provider, Gambino has provided services to 1,591 Medicare beneficiaries, totaling 1,646 services with total Medicare billing of $64,616. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology
- Location Ontario, OR
- Active Since 05/03/2006
- Last Updated 10/04/2013
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1093773533
Products in Payments
- Nubeqa (Drug) $60.16
- FOUNDATIONONE (Device) $15.54
- GEMTESA (Drug) $13.01
- JEVTANA (Drug) $11.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.